Cellply is a biomedical company focused on the development of near-patient diagnostic systems aiming at defining anticancer drug response profiles on ex-vivo patient samples through the analysis of the biological response.

Leveraging on a patented microfluidic technology, highly-integrated cell processing and analysis methods are supported and drug testing in the clinical setting is enabled with a high degree of automation and standardization.